Novartis AG Capital Reinvestment Ratio
Novartis AG capital reinvestment ratio. Novartis AG (NVSN) has a Capital Reinvestment Ratio of 0.22x as of March 2026, meaning it reinvests 0% of its operating cash flow (MX$3.68 Billion) in capital expenditures (MX$807.00 Million). Check how aggressively does Novartis AG reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Novartis AG (2014–2025)
Capital reinvestment ratio of Novartis AG from 2014 to 2025. This chart tracks Novartis AG's Capital Reinvestment Ratio across 12 annual periods. Also explore net asset momentum of Novartis AG to track the company's year-over-year net asset growth rate.
Novartis AG Capital Reinvestment Ratio by Year (2014–2025)
Novartis AG capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see Novartis AG cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (MXN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | MX$19.14 Billion | MX$3.90 Billion | ▼ -5.9% |
| 2024 | 0.22x | MX$17.62 Billion | MX$3.81 Billion | ▲ +19.6% |
| 2023 | 0.18x | MX$16.02 Billion | MX$2.90 Billion | ▲ +115.1% |
| 2022 | 0.08x | MX$14.24 Billion | MX$1.20 Billion | ▼ -8.0% |
| 2021 | 0.09x | MX$15.07 Billion | MX$1.38 Billion | ▼ -2.1% |
| 2020 | 0.09x | MX$13.65 Billion | MX$1.27 Billion | ▼ -7.7% |
| 2019 | 0.10x | MX$13.62 Billion | MX$1.38 Billion | ▲ +15.2% |
| 2018 | 0.09x | MX$14.27 Billion | MX$1.25 Billion | ▼ -16.3% |
| 2017 | 0.10x | MX$12.62 Billion | MX$1.32 Billion | ▼ -58.2% |
| 2016 | 0.25x | MX$11.47 Billion | MX$2.88 Billion | ▲ +26.1% |
| 2015 | 0.20x | MX$11.90 Billion | MX$2.37 Billion | ▲ +5.4% |
| 2014 | 0.19x | MX$13.90 Billion | MX$2.62 Billion | — |